MétaCan
Menu
Back to cohort
Record W4285803892 · doi:10.3233/jad-220399

Comparative Analysis of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

2022· article· en· W4285803892 on OpenAlexfundno aff
Jigyasha Timsina, Duber Gomez‐Fonseca, Lihua Wang, Anh Do, Daniel Western, Ignacio Álvarez, Miquel Aguilar, Pau Pástor, Rachel L. Henson, Elizabeth Herries, Chengjie Xiong, Suzanne E. Schindler, Anne M. Fagan, Randall J. Bateman, Martin R. Farlow, John C. Morris, Richard J. Perrin, Krista L. Moulder, Jason Hassenstab, Jonathan Vöglein, Jasmeer P. Chhatwal, Hiroshi Mori

Bibliographic record

VenueJournal of Alzheimer s Disease · 2022
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsnot available
FundersNational Institute on AgingInstituto de Salud Carlos IIICanadian Institutes of Health ResearchGenentechNational Institutes of HealthFleniIXICODeutsches Zentrum für Neurodegenerative ErkrankungenH. Lundbeck A/SServierEisaiKorea Health Industry Development InstituteNorthern California Institute for Research and EducationJapan Agency for Medical Research and DevelopmentBioClinicaBiogenPfizerNovartis Pharmaceuticals CorporationHope Center for Neurological DisordersUniversity of Southern CaliforniaU.S. Department of DefenseEli Lilly and CompanyBristol-Myers SquibbFondation Brain CanadaAlzheimer's Disease Neuroimaging InitiativeMeso Scale DiagnosticsAlzheimer's Association
KeywordsMultiplexImmunoassayCerebrospinal fluidMedicineDiseaseAlzheimer's diseasePathologyImmunologyAntibodyBiologyBioinformatics

Abstract

fetched live from OpenAlex

BACKGROUND: The SOMAscan assay has an advantage over immunoassay-based methods because it measures a large number of proteins in a cost-effective manner. However, the performance of this technology compared to the routinely used immunoassay techniques needs to be evaluated. OBJECTIVE: We performed comparative analyses of SOMAscan and immunoassay-based protein measurements for five cerebrospinal fluid (CSF) proteins associated with Alzheimer's disease (AD) and neurodegeneration: NfL, Neurogranin, sTREM2, VILIP-1, and SNAP-25. METHODS: We compared biomarkers measured in ADNI (N = 689), Knight-ADRC (N = 870), DIAN (N = 115), and Barcelona-1 (N = 92) cohorts. Raw protein values were transformed using z-score in order to combine measures from the different studies. sTREM2 and VILIP-1 had more than one analyte in SOMAscan; all available analytes were evaluated. Pearson's correlation coefficients between SOMAscan and immunoassays were calculated. Receiver operating characteristic curve and area under the curve were used to compare prediction accuracy of these biomarkers between the two platforms. RESULTS: Neurogranin, VILIP-1, and NfL showed high correlation between SOMAscan and immunoassay measures (r > 0.9). sTREM2 had a fair correlation (r > 0.6), whereas SNAP-25 showed weak correlation (r = 0.06). Measures in both platforms provided similar predicted performance for all biomarkers except SNAP-25 and one of the sTREM2 analytes. sTREM2 showed higher AUC for SOMAscan based measures. CONCLUSION: Our data indicate that SOMAscan performs as well as immunoassay approaches for NfL, Neurogranin, VILIP-1, and sTREM2. Our study shows promise for using SOMAscan as an alternative to traditional immunoassay-based measures. Follow-up investigation will be required for SNAP-25 and additional established biomarkers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.469
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.074
GPT teacher head0.325
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations69
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Alzheimer s DiseaseSame topicAlzheimer's disease research and treatmentsFrench-language works237,207